With only 6–8% of applicants funded, the EIC Accelerator rewards strategic preparation, not chance. Success consistently comes down to three elements: complete teams that combine technical depth with regulatory and commercial expertise; credible market pull demonstrated through LOIs, pilots or strategic partnerships; and a clear European trajectory showing how value will be created in the EU over the next 24–36 months.

Sector dynamics also matter: medical devices account for more than a third of funded projects, while biotherapeutics, digital health and livestock technologies require strong differentiation to rise above the competition. The strongest applicants invest months in strengthening teams, generating evidence and shaping a compelling European growth story before applying.

At Strategic Healthcare Advisors, we support innovators in building these foundations and aligning their strategy with evaluator expectations.

In this episode, Dr Caroline Chauché outlines the real drivers of EIC Accelerator success — and what startups must do to position themselves effectively.